Treatment of thyrotoxicosis--the current position. I. Classification, causation and treatment.
D000236:Adenoma / Q000601:surgery; D000328:Adult; D000917:Antibody Formation; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D006044:Goiter, Nodular / Q000209:etiology; D006111:Graves Disease / Q000209:etiology; D006801:Humans; D006980:Hyperthyroidism / Q000145:classification / Q000151:congenital / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D007231:Infant, Newborn; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008135:Long-Acting Thyroid Stimulator / Q000502:physiology; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D013963:Thyroid Hormones / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000601:surgery; D013965:Thyroidectomy; D013972:Thyrotropin / Q000502:physiology; D006113:United Kingdom
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D002231:Carbimazole; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator